Permanent unilateral hearing loss after radiotherapy for parotid gland tumors

Lisa van der Putten, Remco de Bree*, John T. Plukker, Johannes A. Langendijk, Cas Smits, Fred R. Burlage, C. Rene Leemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

45 Citations (Scopus)

Abstract

Background. The purpose of this retrospective study was to determine the long-term effects of radiotherapy on hearing function in patients who underwent parotidectomy and postoperative radiotherapy for unilateral tumors of the parotid gland.

Methods, An extensive set of tests was used to measure hearing loss. The mean dose on middle ear, cochlea, and Eustachian tube was estimated with a CT-planning system.

Results. A hearing loss of >= 15 dB in 3 frequencies was found in 32% of the 52 patients included in the study. Patients with an asymmetrical hearing loss received a higher mean dose on the hearing structures (p <.002). The threshold dose for clinically relevant hearing loss was found at 50 Gy on the cochlea and Eustachian tube.

Conclusions. Radiation-induced hearing loss is a common complication. A mean dose of > 50 Gy on the cochlea should be avoided. (c) 2006 Wiley Periodicals, Inc.

Original languageEnglish
Pages (from-to)902-908
Number of pages7
JournalHead and Neck: Journal of the Sciences and Specialties of the Head and Neck
Volume28
Issue number10
DOIs
Publication statusPublished - Oct-2006

Keywords

  • hearing loss
  • radiotherapy
  • parotid tumor
  • audiometry
  • CT-planning
  • NASOPHARYNGEAL CARCINOMA
  • RADIATION
  • IMPAIRMENT
  • EAR

Fingerprint

Dive into the research topics of 'Permanent unilateral hearing loss after radiotherapy for parotid gland tumors'. Together they form a unique fingerprint.

Cite this